This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
XARELTO - How Supplied
Last Updated: 05/15/2026
SUMMARY
- XARELTO is supplied in the United States as a tablet (2.5 mg, 10 mg, 15 mg, and 20 mg) and granules in an amber glass bottle (1 mg/mL oral suspension once reconstituted).1
PRODUCT LABELING
Please refer to the following sections of the enclosed Full Prescribing Information1 that are relevant to your inquiry: DOSAGE FORMS AND STRENGTHS and HOW SUPPLIED/STORAGE AND HANDLING.
XARELTO (rivaroxaban) tablets are available in the strengths and packages listed below:
The 2.5 mg tablets are round, light yellow, and film-coated with a triangle pointing down above a “2.5” marked on one side and “Xa” on the other side.1 See Figures: Xa (2.5 mg) Front and 2.5 mg Rear. The tablets are supplied in the packages listed. See Figure: 2.5 mg Bottle Image.
The 10 mg tablets are round, light red, biconvex and film-coated with a triangle pointing down above a “10” marked on one side and “Xa” on the other side.1 See Figures: Xa (10 mg) Front and 10 mg Rear. The tablets are supplied in the packages listed. See Figures: 10 mg Box Image and 10 mg Bottle Image.
The 15 mg tablets are round, red, biconvex, and film-coated with a triangle pointing down above a “15” marked on one side and “Xa” on the other side.1 See Figures: Xa (15 mg) Front and 15 mg Rear.
The 20 mg tablets are triangle-shaped, dark red, and film-coated with a triangle pointing down above a “20” marked on one side and “Xa” on the other side.1 See Figures: Xa (20 mg) Front and 20 mg Rear.
The Starter Pack for treatment of deep vein thrombosis and treatment of pulmonary embolism is a 30-day starter blister pack containing 51 tablets: 42 tablets of 15 mg and 9 tablets of 20 mg.1 See Figures: Starter Pack and Starter Pack Interior and Contents.
See Table: XARELTO Tablets Strengths and Packages.
| NDC Code | Tablet Strength | Package | |
|---|---|---|---|
| NDC 50458-577-60 | 2.5 mg | Bottle containing 60 tablets | |
| NDC 50458-577-18 | 2.5 mg | Bottle containing 180 tablets | |
| NDC 50458-577-10 | 2.5 mg | Blister package containing 100 tablets (10 blister cards containing 10 tablets each) | |
| NDC 50458-580-30 | 10 mg | Bottle containing 30 tablets | |
| NDC 50458-580-90 | 10 mg | Bottle containing 90 tablets | |
| NDC 50458-580-10 | 10 mg | Blister package containing 100 tablets (10 blister cards containing 10 tablets each) | |
| NDC 50458-578-30 | 15 mg | Bottle containing 30 tablets | |
| NDC 50458-578-90 | 15 mg | Bottle containing 90 tablets | |
| NDC 50458-578-10 | 15 mg | Blister package containing 100 tablets (10 blister cards containing 10 tablets each) | |
| NDC 50458-579-30 | 20 mg | Bottle containing 30 tablets | |
| NDC 50458-579-90 | 20 mg | Bottle containing 90 tablets | |
| NDC 50458-579-89 | 20 mg | Bulk bottle containing 1000 tablets | |
| NDC 50458-579-10 | 20 mg | Blister package containing 100 tablets (10 blister cards containing 10 tablets each) | |
| NDC 50458–584–51 | Starter Pack | Blister pack containing 51 tablets | |
| Abbreviation: NDC, National Drug Code. | |||
XARELTO (rivaroxaban) for oral suspension is available in the strength and package listed below. See Table: XARELTO Oral Suspension Strength and Package .
| NDC Code | Package |
|---|---|
| NDC 50458-575-01 | Supplied as white to off-white granules in an amber glass bottle containing 155 mg rivaroxaban packaged with two oral dosing syringes. After reconstitution with 150 mL of purified water, 1 mL of the suspension contains 1 mg rivaroxaban. |
| Abbreviation: NDC, National Drug Code. | |
Discard reconstituted suspension after “Discard after” date written on the bottle.1
Storage of tablets, granules, and reconstituted suspension: Store at room temperature between 20C to 25C (68F to 77F); excursions permitted to 15C to 30C (59F to 86F; see United States Pharmacopeia [USP] Controlled Room Temperature).1
Do not freeze the granules or reconstituted suspension.1
Keep out of the reach of children.1
TABLET AND PACKAGE ILLUSTRATIONS
LITERATURE SEARCH
References
| 1 | XARELTO (rivaroxaban) [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/XARELTO-pi.pdf |